Q1 2017 XBiotech Inc Earnings Call

4/5/2017 8:30

Conference Call XBiotech Inc

XBiotech Inc Conference call or earnings call will be held on May 4, 2017
During the earnings conference call’s session, XBiotech Inc will provide updated information and financial performance report status.
In order to join the earning call, dial the conference’s bridge and key in the PIN code. Contact XBiotech Inc for this information
More and more companies choose to conduct their earnings calls through conference calls and online meetings and it’s important to keep up to date with all relevant information.
Need a conference calls service solution? Try QCONF conferencing today, Sign up now and get 5 free conference calls (no credit card required)
Is this is your first earnings call? Check out Nasdaq guide for how to read an earnings report?
XBiotech is a clinical-stage biopharmaceutical company engaged in discovering and developing True Human(TM) monoclonal antibodies for treating a variety of diseases. True Human(TM) monoclonal antibodies are those which occur naturally in human beings--as opposed to being derived from animal immunization or otherwise engineered. We believe that naturally occurring monoclonal antibodies have the potential to be safer and more effective than their non-naturally occurring counterparts. While focused on bringing our lead product candidate to market, we also have developed a True Human(TM) pipeline and manufacturing system. The majority of our efforts to date have been concentrated on developing MABp1 (also known as Xilonix(TM), CA-18C3, CV-18C3, RA-18C3, and T2-18C3), a therapeutic antibody which specifically neutralizes interleukin-1 alpha (IL-1a). IL-1ais a pro-inflammatory protein produced by leukocytes and other cells, where it plays a key role in inflammation.    
Read more Conference Call

XBiotech Inc (XBIT)

8201 East Riverside Drive, Austin Texas 78744, United States